Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Congreso Oncológico ecancer - Liga Colombiana contra el Cáncer /
Next steps for treating breast cancer

17th - 18th Nov 2016

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 06.01.17
Views: 1791
Rating:

Dr Michel Velez - Memorial Healthcare System, Hollywood, FL, USA

Dr Velez speaks with ecancertv at the ecancer Colombian Cancer Congress about immunotherapy and CDK4/6 inhibition in the treatment of breast cancer.

Considering preliminary results from immunotherapy trials, he considers how immune modulation might become part of a larger arsenal, in combination or adjuvant settings.

CDK inhibition for breast cancer therapy was discussed further in an expert round-table session at SABCS 2016,  and in a special ecancer symposium session at ESMO 2016.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation